UB-612previously rejected because it did not match up to AstraZeneca vaccine

UBI is second Taiwanese company to develop own vaccine

Three Taiwanese coronavirus vaccine makers could enter phase 2 clinical trials by years end

Taiwan's UBI Asia to start human clinical trials for COVID-19 vaccine in a few days